BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 18471804)

  • 1. Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK1 receptor antagonists.
    Darmani NA; Wang Y; Abad J; Ray AP; Thrush GR; Ramirez J
    Brain Res; 2008 Jun; 1214():58-72. PubMed ID: 18471804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic antiemetic interactions between serotonergic 5-HT3 and tachykininergic NK1-receptor antagonists in the least shrew (Cryptotis parva).
    Darmani NA; Chebolu S; Amos B; Alkam T
    Pharmacol Biochem Behav; 2011 Oct; 99(4):573-9. PubMed ID: 21683089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablation of least shrew central neurokinin NK1 receptors reduces GR73632-induced vomiting.
    Ray AP; Chebolu S; Ramirez J; Darmani NA
    Behav Neurosci; 2009 Jun; 123(3):701-6. PubMed ID: 19485577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Δ
    Darmani NA; Belkacemi L; Zhong W
    Eur J Pharmacol; 2019 Dec; 865():172806. PubMed ID: 31738934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pivotal role of glycogen synthase kinase 3 (GSK-3) in vomiting evoked by specific emetogens in the least shrew (Cryptotis parva).
    Zhong W; Darmani NA
    Neurochem Int; 2020 Jan; 132():104603. PubMed ID: 31738972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central and peripheral emetic loci contribute to vomiting evoked by the Akt inhibitor MK-2206 in the least shrew model of emesis.
    Zhong W; Chebolu S; Darmani NA
    Eur J Pharmacol; 2021 Jun; 900():174065. PubMed ID: 33775646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular emetic signaling cascades by which the selective neurokinin type 1 receptor (NK
    Zhong W; Chebolu S; Darmani NA
    Neurochem Int; 2019 Jan; 122():106-119. PubMed ID: 30453005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thapsigargin-induced activation of Ca(2+)-CaMKII-ERK in brainstem contributes to substance P release and induction of emesis in the least shrew.
    Zhong W; Chebolu S; Darmani NA
    Neuropharmacology; 2016 Apr; 103():195-210. PubMed ID: 26631534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological characterisation of tachykinin receptors in the rat nucleus of the solitary tract and dorsal motor nucleus of the vagus in vitro.
    Maubach KA; Jones RS
    Br J Pharmacol; 1997 Nov; 122(6):1151-9. PubMed ID: 9401780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-selective agonists induce emesis and Fos expression in the brain and enteric nervous system of the least shrew (Cryptotis parva).
    Ray AP; Chebolu S; Darmani NA
    Pharmacol Biochem Behav; 2009 Nov; 94(1):211-8. PubMed ID: 19699757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delta 9-tetrahydrocannabinol suppresses vomiting behavior and Fos expression in both acute and delayed phases of cisplatin-induced emesis in the least shrew.
    Ray AP; Griggs L; Darmani NA
    Behav Brain Res; 2009 Jan; 196(1):30-6. PubMed ID: 18721829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad-spectrum antiemetic potential of the L-type calcium channel antagonist nifedipine and evidence for its additive antiemetic interaction with the 5-HT(3) receptor antagonist palonosetron in the least shrew (Cryptotis parva).
    Darmani NA; Zhong W; Chebolu S; Vaezi M; Alkam T
    Eur J Pharmacol; 2014 Jan; 722():2-12. PubMed ID: 24513517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclophosphamide causes activation of protein kinase A (PKA) in the brainstem of vomiting least shrews (Cryptotis parva).
    Alkam T; Chebolu S; Darmani NA
    Eur J Pharmacol; 2014 Jan; 722():156-64. PubMed ID: 24513510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of T-2328, 2-fluoro-4'-methoxy-3'-[[[(2S,3S)-2-phenyl-3-piperidinyl]amino]methyl]-[1,1'-biphenyl]-4-carbonitrile dihydrochloride, as a brain-penetrating antagonist of tachykinin NK1 receptor.
    Watanabe Y; Asai H; Ishii T; Kiuchi S; Okamoto M; Taniguchi H; Nagasaki M; Saito A
    J Pharmacol Sci; 2008 Jan; 106(1):121-7. PubMed ID: 18187929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delta-9-tetrahydrocannabinol differentially suppresses emesis versus enhanced locomotor activity produced by chemically diverse dopamine D2/D3 receptor agonists in the least shrew (Cryptotis parva).
    Darmani NA; Crim JL
    Pharmacol Biochem Behav; 2005 Jan; 80(1):35-44. PubMed ID: 15652378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA sequencing least shrew (
    Irizarry KJL; Zhong W; Sun Y; Kronmiller BA; Darmani NA
    Front Genet; 2023; 14():975087. PubMed ID: 36865388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tachykinin NK1 receptor antagonist PD 154075 blocks cisplatin-induced delayed emesis in the ferret.
    Singh L; Field MJ; Hughes J; Kuo BS; Suman-Chauhan N; Tuladhar BR; Wright DS; Naylor RJ
    Eur J Pharmacol; 1997 Feb; 321(2):209-16. PubMed ID: 9063690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for Bell-Shaped Dose-Response Emetic Effects of Temsirolimus and Analogs: The Broad-Spectrum Antiemetic Efficacy of a Large Dose of Temsirolimus Against Diverse Emetogens in the Least Shrew (
    Belkacemi L; Sun Y; Darmani NA
    Front Pharmacol; 2022; 13():848673. PubMed ID: 35444553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broad-spectrum antiemetic efficacy of the L-type calcium channel blocker amlodipine in the least shrew (Cryptotis parva).
    Zhong W; Chebolu S; Darmani NA
    Pharmacol Biochem Behav; 2014 May; 120():124-32. PubMed ID: 24631485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparative Study of the Antiemetic Effects of α
    Sun Y; Darmani NA
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.